Benzinga

Benzinga

Benzinga

miércoles, agosto 19

Doximity Inc

DOCSNYSE
Trade with Public
Trade with Public
$24.94
0.421.71%
al cierre: Aug 17, 5:00 PM EST
$24.86
0.341.39%
Premercado: 6:04 AM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Doximity Analyst Price Targets

Wall Street analyst price targets and consensus rating for Doximity (DOCS).

Price Target Range — 8 Quarters

Analyst Consensus — 19 Analysts

1S.Buy
7Buy
9Hold
2Sell
Consensus RatingNeutral# Analysts19Avg. Consensus PT$35Upside to Avg. PT+42.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 13, 2026Truist SecuritiesJailendra SinghPT RaiseHold$19→$24
Aug 10, 2026Wells FargoStan BerenshteynDowngradeEqual-Weight→Underweight$18
More with Benzinga EdgeGet Access

Analyst Ratings News

Russell 2000 Extends Records, SanDisk Rallies 7%: Stock Market Today

Small caps hit fresh highs Friday as soft retail sales and weak sentiment stalled the S&P 500, while crude climbed and SanDisk extended its post-Investor Day run.
Piero Cingari

PRO
Truist Securities Maintains Hold on Doximity, Raises Price Target to $24

Truist Securities analyst Jailendra Singh maintains Doximity (NYSE:DOCS) with a Hold and raises the price target from $19 to $24.
Benzinga Newsdesk

PRO
Wells Fargo Downgrades Doximity to Underweight, Maintains Price Target to $18

Wells Fargo analyst Stan Berenshteyn downgrades Doximity (NYSE:DOCS) from Equal-Weight to Underweight and maintains the price target from $18 to $18.
Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Doximity, Raises Price Target to $31

JP Morgan analyst Alexei Gogolev maintains Doximity (NYSE:DOCS) with a Neutral and raises the price target from $26 to $31.
Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on Doximity, Raises Price Target to $47

Piper Sandler analyst Jessica Tassan reiterates Doximity (NYSE:DOCS) with a Overweight and raises the price target from $42 to $47.
Benzinga Newsdesk

Doximity's AI Expansion Raises Execution Risks: Analyst

BofA downgrades Doximity (DOCS) to Underperform, slashing the price target to $20 amid soft pharma ad demand and AI execution risks.
Vandana Singh

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved